TALOXA 600 mg/5 ml, oral suspension bottle, 230 ml
Active ingredients: Felbamate
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 230 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TALOXA 600 mg/5 ml suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 230 ml avec seringue(s) doseuse(s)
- Marketing authorisation holder
- ORGANON FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jul 1996
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62313468CIP75591589CIP133400955915898Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FELBAMATEsuspension | 600 mg · 5 ml de suspension buvable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.